MEP3708A - Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use - Google Patents
Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their useInfo
- Publication number
- MEP3708A MEP3708A MEP-37/08A MEP3708A MEP3708A ME P3708 A MEP3708 A ME P3708A ME P3708 A MEP3708 A ME P3708A ME P3708 A MEP3708 A ME P3708A
- Authority
- ME
- Montenegro
- Prior art keywords
- wort
- john
- pharmaceutical compositions
- proteins
- hypericum perforatum
- Prior art date
Links
- 244000141009 Hypericum perforatum Species 0.000 title 2
- 235000017309 Hypericum perforatum Nutrition 0.000 title 2
- 241001441361 Usnea barbata Species 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 238000005277 cation exchange chromatography Methods 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/09—Lichens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04009213A EP1591125A1 (de) | 2004-04-19 | 2004-04-19 | Pharmazeutische Zusammensetzung enthaltend Extrakte aus Flechten und Johanniskraut |
| PCT/EP2005/003657 WO2005099728A1 (de) | 2004-04-19 | 2005-04-07 | Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP3708A true MEP3708A (en) | 2010-06-10 |
Family
ID=34924650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-37/08A MEP3708A (en) | 2004-04-19 | 2005-04-07 | Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7687083B2 (es) |
| EP (2) | EP1591125A1 (es) |
| AT (1) | ATE376427T1 (es) |
| CA (1) | CA2563870C (es) |
| DE (1) | DE502005001791D1 (es) |
| ES (1) | ES2294697T3 (es) |
| HR (1) | HRP20070579T3 (es) |
| ME (1) | MEP3708A (es) |
| PL (1) | PL1755630T3 (es) |
| RS (1) | RS50550B (es) |
| RU (1) | RU2358750C2 (es) |
| SI (1) | SI1755630T1 (es) |
| WO (1) | WO2005099728A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2448577T3 (pl) * | 2009-06-30 | 2017-02-28 | Derman Biomedicine Co. Ltd. | Kompozycje zawierające berberynę lub jej analogi do leczenia trądziku różowatego lub chorób skóry związanych z zaczerwienieniem twarzy |
| GB0919210D0 (en) * | 2009-11-03 | 2009-12-16 | Syntopix Ltd | Formulations |
| GB201021745D0 (en) * | 2010-12-22 | 2011-02-02 | Syntopix Group Plc | Formulations |
| CN102949298A (zh) * | 2011-12-20 | 2013-03-06 | 上海莱博生物科技有限公司 | 松萝酸和/或其盐的应用 |
| RS54162B1 (en) * | 2011-12-28 | 2015-12-31 | Univerzitet U Beogradu | PHARMACEUTICAL COMPOSITION BASED ON MEDICINAL HERBS FOR HUMAN AND VETERINARY MEDICINAL PRODUCTS |
| RU2582978C2 (ru) * | 2014-01-14 | 2016-04-27 | Федеральное государственное бюджетное учреждение науки Институт экологических проблем Севера Уральского отделения Российской академии наук | СПОСОБ ПОЛУЧЕНИЯ ТВЕРДОГО ЭКСТРАКТА, ОБОГАЩЕННОГО УСНИНОВОЙ КИСЛОТОЙ, ИЗ СЛОЕВИЩ ЛИШАЙНИКА РОДА "Cladonia" |
| CN105076246A (zh) * | 2015-08-28 | 2015-11-25 | 无限极（中国）有限公司 | 一种抗菌中药组合物及其制备方法、应用 |
| US20190358327A1 (en) * | 2016-12-23 | 2019-11-28 | Klox Technologies Inc. | Biophotonic compositions comprising lichen extract and their use to treat skin disorders |
| CN106943341B (zh) * | 2017-05-10 | 2020-01-24 | 重庆理工大学 | 一种改善松萝酸透皮吸收的外用制剂及其在促皮肤创伤愈合中的应用 |
| US11517512B2 (en) * | 2017-07-19 | 2022-12-06 | Colgate-Palmolive Company | Personal care compositions comprising zinc : usnic acid complexes and methods of use |
| CN108938509B (zh) * | 2018-10-16 | 2021-06-18 | 头皮医生健康管理(中国)有限公司 | 去屑止痒组合物及其制备方法和其应用 |
| EP4125982A1 (en) * | 2020-03-23 | 2023-02-08 | Kerecis AG | Antimicrobial solutions and methods of using the same in the treatment or prevention of infections |
| IT202000008536A1 (it) | 2020-04-21 | 2021-10-21 | Pellegrino Masiello | Composizione e metodo per il trattamento delle fasi intermedie della covid-19 e simili patologie virali con risposta infiammatoria sistemica |
| CN113876645B (zh) * | 2020-07-01 | 2024-01-05 | 伽蓝（集团）股份有限公司 | 一种须松萝提取物及其应用和含其的皮肤外用剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05246876A (ja) * | 1992-03-07 | 1993-09-24 | Nippon Paint Co Ltd | 抗菌剤 |
| JPH0818956B2 (ja) * | 1993-06-14 | 1996-02-28 | 花王株式会社 | 養毛・育毛料 |
| DE10131641A1 (de) * | 2000-12-22 | 2002-06-27 | Schwabe Willmar Gmbh & Co | Verbesserter und stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und Verwendung als topisches Arzneimittel |
| IL143318A0 (en) * | 2001-05-23 | 2002-04-21 | Herbal Synthesis Corp | Herbal compositions for the treatment of mucosal lesions |
-
2004
- 2004-04-19 EP EP04009213A patent/EP1591125A1/de not_active Withdrawn
-
2005
- 2005-04-07 AT AT05731107T patent/ATE376427T1/de active
- 2005-04-07 PL PL05731107T patent/PL1755630T3/pl unknown
- 2005-04-07 RU RU2006140864/15A patent/RU2358750C2/ru not_active IP Right Cessation
- 2005-04-07 ME MEP-37/08A patent/MEP3708A/xx unknown
- 2005-04-07 CA CA2563870A patent/CA2563870C/en not_active Expired - Fee Related
- 2005-04-07 ES ES05731107T patent/ES2294697T3/es active Active
- 2005-04-07 WO PCT/EP2005/003657 patent/WO2005099728A1/de active Application Filing
- 2005-04-07 RS RSP-2007/0495A patent/RS50550B/sr unknown
- 2005-04-07 DE DE502005001791T patent/DE502005001791D1/de active Active
- 2005-04-07 EP EP05731107A patent/EP1755630B1/de active Active
- 2005-04-07 SI SI200530113T patent/SI1755630T1/sl unknown
- 2005-04-07 US US11/578,962 patent/US7687083B2/en not_active Expired - Fee Related
-
2007
- 2007-12-24 HR HR20070579T patent/HRP20070579T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005099728A1 (de) | 2005-10-27 |
| DE502005001791D1 (de) | 2007-12-06 |
| RU2358750C2 (ru) | 2009-06-20 |
| SI1755630T1 (sl) | 2008-02-29 |
| ES2294697T3 (es) | 2008-04-01 |
| ATE376427T1 (de) | 2007-11-15 |
| PL1755630T3 (pl) | 2008-03-31 |
| US20080233145A1 (en) | 2008-09-25 |
| EP1755630A1 (de) | 2007-02-28 |
| EP1591125A1 (de) | 2005-11-02 |
| HRP20070579T3 (en) | 2008-01-31 |
| RS50550B (sr) | 2010-05-07 |
| EP1755630B1 (de) | 2007-10-24 |
| US7687083B2 (en) | 2010-03-30 |
| RU2006140864A (ru) | 2008-05-27 |
| CA2563870C (en) | 2013-02-19 |
| CA2563870A1 (en) | 2005-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP3708A (en) | Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use | |
| MEP3408A (en) | Process for the purification of pharmacologically active proteins through cationic exchange chromatography | |
| CY1117358T1 (el) | ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ | |
| HRP20050371B1 (hr) | Oblik za primjenu farmaceutiski djelatnih peptida s produljenim oslobađanjem djelatnog sastojka i postupak za njihovu proizvodnju | |
| PE20080121A1 (es) | Metodos para reducir la aglomeracion de proteina | |
| DK0784632T3 (da) | Fremgangsmåde til udvinding af højren von Willebrand-faktor | |
| CR8998A (es) | PRODUCCION DE TNFR-Ig Y FUSION DE PROTEINA | |
| DK1075488T3 (da) | Proteinoprensning ved ionbytningskromatografi | |
| RU2012130151A (ru) | Промывочный раствор и способ промывки для аффинной хроматографии | |
| DE69132671T2 (de) | Protein-g-gekoppelte glutaminsäure-rezeptoren | |
| AR051512A1 (es) | Proteina de fusion que comprende un dominio bh3 de una proteina "solo bh3" | |
| JP2010524472A5 (es) | ||
| BR0312521A (pt) | Métodos para a separação e a purificação de fibrinogênio e de pelo menos uma outra proteìna e para a co-purificação de fibrinogênio e de fator xiii, uso de cromatografia de afinidade com ìon de metal imobilizado, fibrinogênio, kit farmacêutico, e, formulações farmacêutica e de fibrinogênio liofilizado | |
| CY1107514T1 (el) | Μια μεθοδος για την εκχυλιση, καθαρισμο και ενζυματικη τροποποιηση της α’ υπομοναδας σογια 7s σφαιρινης για να χρησιμοποιηθει ως παραγων που προκαλει υποχολεστepολαιμια | |
| RS53083B (en) | RECOMBINANT ELASTASIS PROTEINS AND THE METHODS OF PRODUCTION AND USE OF THE SAME | |
| BRPI0407533A (pt) | proteìnas de fusão e muteìnas do interferon alfa com propriedades melhoradas | |
| CY1110296T1 (el) | Χρηση αμινων ή αμινοξεων ως τροποποιητες κινητης φασης στη χρωματογραφια | |
| DE60230312D1 (de) | Verfahren zur proteinreinigung | |
| DK1219301T3 (da) | Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner | |
| ES2192199T3 (es) | Ligandos de la familia eph biologicamente activos. | |
| DE69839733D1 (de) | Mit syndekan interagierende proteine und deren verwendung | |
| ATE496133T1 (de) | Affinitätspolypeptid zur reinigung von rekombinanten proteinen | |
| US6613737B1 (en) | Process for the purification of a new motility-promoting protein from buffalo serum: a slaughter house waste | |
| HUP0303554A2 (hu) | Eljárás oldhatatlan zárványként exprimált rekombináns proteinek tisztítására | |
| DK1633859T3 (da) | Cellelinje og anvendelser heraf |